Absence of functional peroxisomes does not lead to deficiency of enzymes involved in cholesterol biosynthesis.
暂无分享,去创建一个
H. Waterham | R. Wanders | S. Houten | M. Baes | S. Hogenboom | G. Romeijn
[1] A. Honda,et al. Accurate detection of Smith–Lemli–Opitz syndrome carriers by measurement of the rate of reduction of the ergosterol C-7 double bond in cultured skin fibroblasts , 1998, Journal of Inherited Metabolic Disease.
[2] R. Wanders,et al. Infantile Refsum disease: an inherited peroxisomal disorder , 1987, European Journal of Pediatrics.
[3] I. Vanhorebeek,et al. Isoprenoid biosynthesis is not compromised in a Zellweger syndrome mouse model , 2001 .
[4] S. Krisans,et al. Peroxisomal protein targeting and identification of peroxisomal targeting signals in cholesterol biosynthetic enzymes. , 2000, Biochimica et biophysica acta.
[5] D. Valle,et al. Peroxisome biogenesis disorders: genetics and cell biology. , 2000, Trends in genetics : TIG.
[6] R. Hennekam,et al. The Smith-Lemli-Opitz syndrome , 2000, Journal of Medical Genetics.
[7] T. Tansey,et al. Differential binding of proteins to peroxisomes in rat hepatoma cells: unique association of enzymes involved in isoprenoid metabolism. , 1999, Journal of lipid research.
[8] L. Hagenfeldt,et al. Synthesis of Mevalonate Pathway Lipids in Fibroblasts from Zellweger and X-linked ALD Patients , 1999, Pediatric Research.
[9] H. Waterham,et al. Identification and characterization of three novel missense mutations in mevalonate kinase cDNA causing mevalonic aciduria, a disorder of isoprene biosynthesis. , 1999, Human molecular genetics.
[10] K. Gibson,et al. Characterization of phosphomevalonate kinase: chromosomal localization, regulation, and subcellular targeting. , 1999, Journal of lipid research.
[11] R. Wanders,et al. Differential deficiency of mevalonate kinase and phosphomevalonate kinase in patients with distinct defects in peroxisome biogenesis: evidence for a major role of peroxisomes in cholesterol biosynthesis. , 1998, Biochemical and biophysical research communications.
[12] Robert V Farese,et al. Cholesterol metabolism and embryogenesis. , 1998, Trends in genetics : TIG.
[13] T. Tsukamoto,et al. Peroxisome Targeting Signal Type 1 (PTS1) Receptor Is Involved in Import of Both PTS1 and PTS2: Studies withPEX5-Defective CHO Cell Mutants , 1998, Molecular and Cellular Biology.
[14] P. Carmeliet,et al. A mouse model for Zellweger syndrome , 1997, Nature Genetics.
[15] S. Krisans,et al. Cloning and Subcellular Localization of Hamster and Rat Isopentenyl Diphosphate Dimethylallyl Diphosphate Isomerase , 1997, The Journal of Biological Chemistry.
[16] H. Tabak,et al. Rhizomelic chondrodysplasia punctata is a peroxisomal protein targeting disease caused by a non-functional PTS2 receptor , 1997, Nature Genetics.
[17] S. Subramani. Protein Translocation into Peroxisomes* , 1996, The Journal of Biological Chemistry.
[18] I. Singh,et al. Abnormality in Translational Regulation of Catalase Expression in Disorders of Peroxisomal Biogenesis , 1996, Journal of neurochemistry.
[19] S. Krisans,et al. Compartmentalization of Cholesterol Biosynthesis , 1996, The Journal of Biological Chemistry.
[20] R. Wanders,et al. Peroxisomal disorders: a review. , 1995, Journal of neuropathology and experimental neurology.
[21] H. Mandel,et al. Reduced cellular cholesterol content in peroxisome-deficient fibroblasts is associated with impaired uptake of the patient's low density lipoprotein and with reduced cholesterol synthesis. , 1995, Journal of lipid research.
[22] G. Kostner,et al. Cholesterol biosynthesis in dermal fibroblasts from patients with metabolic disorders of peroxisomal origin , 1995, European journal of clinical investigation.
[23] R. Wanders,et al. Purification of peroxisomal acyl-CoA: dihydroxyacetonephosphate acyltransferase from human placenta. , 1994, Biochimica et biophysica acta.
[24] P. Edwards,et al. Farnesyl-diphosphate synthase is localized in peroxisomes. , 1994, The Journal of biological chemistry.
[25] G A Keller,et al. Mevalonate kinase is predominantly localized in peroxisomes and is defective in patients with peroxisome deficiency disorders. , 1994, The Journal of biological chemistry.
[26] B. Neel,et al. Solubilization and purification of enzymatically active glutathione S-transferase (pGEX) fusion proteins. , 1993, Analytical biochemistry.
[27] S. Subramani,et al. Protein import into peroxisomes and biogenesis of the organelle. , 1993, Annual review of cell biology.
[28] Victoria J. Hodge,et al. Normal cholesterol synthesis in human cells requires functional peroxisomes. , 1991, Biochemical and biophysical research communications.
[29] J. Goldstein,et al. Regulation of the mevalonate pathway , 1990, Nature.
[30] R. Wanders,et al. Age-related accumulation of phytanic acid in plasma from patients with the cerebro-hepato-renal (Zellweger) syndrome. , 1987, Clinica chimica acta; international journal of clinical chemistry.
[31] R. Wanders,et al. Peroxisomal beta-oxidation of palmitoyl-CoA in human liver homogenates and its deficiency in the cerebro-hepato-renal (Zellweger) syndrome. , 1986, Clinica chimica acta; international journal of clinical chemistry.
[32] S. Singer,et al. 3-Hydroxy-3-methylglutaryl-coenzyme A reductase is present in peroxisomes in normal rat liver cells. , 1985, Proceedings of the National Academy of Sciences of the United States of America.
[33] J. Kyhse-Andersen. Electroblotting of multiple gels: a simple apparatus without buffer tank for rapid transfer of proteins from polyacrylamide to nitrocellulose. , 1984, Journal of biochemical and biophysical methods.
[34] M. M. Bradford. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. , 1976, Analytical biochemistry.
[35] M. Brown,et al. Regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase activity in cultured human fibroblasts. Comparison of cells from a normal subject and from a patient with homozygous familial hypercholesterolemia. , 1974, The Journal of biological chemistry.
[36] W. Cleland,et al. Purification and mechanism of action of hog liver mevalonic kinase. , 1970, The Journal of biological chemistry.